Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) as a Novel Diagnostic Serum Biomarker in Pancreatic Ductal Adenocarcinoma

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-14-578
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pancreatic Ductal Adenocarcinoma inBRCA2mutation Carriers: Table 1

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Fibrosis-Related miRNAs as Serum Biomarkers for Pancreatic Ductal Adenocarcinoma

Oncotarget
Oncology
2017English

Macrophage Migration Inhibitory Factor as a Novel Biomarker of Portopulmonary Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2016English

Macrophage Inhibitory Cytokine-1/Growth Differentiation Factor-15 as a Predictor of Colonic Neoplasia

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Current Molecular Medicine
BiochemistryMedicineMolecular MedicineMolecular Biology
2016English

Circulating miR-107 Could Be a Potential Biomarker for Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

Serum Metabolomics as a Novel Diagnostic Approach for Pancreatic Cancer

Metabolomics
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

PSC-induced Galectin-1 Promotes the Malignant Behavior of Pancreatic Ductal Adenocarcinoma

journal of nutritional oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy